Your browser doesn't support javascript.
loading
Glioblastoma-synthesized G-CSF and GM-CSF contribute to growth and immunosuppression: Potential therapeutic benefit from dapsone, fenofibrate, and ribavirin.
Kast, Richard E; Hill, Quentin A; Wion, Didier; Mellstedt, Håkan; Focosi, Daniele; Karpel-Massler, Georg; Heiland, Tim; Halatsch, Marc-Eric.
Afiliação
  • Kast RE; 1 IIAIGC Study Center, Burlington, VT, USA.
  • Hill QA; 2 Department of Haematology, St James's University Hospital, Leeds Teaching Hospitals, Leeds, UK.
  • Wion D; 3 INSERM U1205, Centre de Recherche Biomédicale Edmond J. Safra, Grenoble, France.
  • Mellstedt H; 4 Department of Oncology, Karolinska University Hospital Solna, Stockholm, Sweden.
  • Focosi D; 5 North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy.
  • Karpel-Massler G; 6 Department of Neurosurgery, University of Ulm, Ulm, Germany.
  • Heiland T; 6 Department of Neurosurgery, University of Ulm, Ulm, Germany.
  • Halatsch ME; 6 Department of Neurosurgery, University of Ulm, Ulm, Germany.
Tumour Biol ; 39(5): 1010428317699797, 2017 May.
Article em En | MEDLINE | ID: mdl-28459367

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fator Estimulador de Colônias de Granulócitos / Fator Estimulador de Colônias de Granulócitos e Macrófagos / Terapia de Imunossupressão / Glioblastoma Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fator Estimulador de Colônias de Granulócitos / Fator Estimulador de Colônias de Granulócitos e Macrófagos / Terapia de Imunossupressão / Glioblastoma Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article